Phase I, Monocentric, Double-blind, Randomized Study to Assess Tolerability, Safety and Pharmacokinetics of ACH15 After Single Dose and Multiple Doses in Healthy Male Volunteers

Trial Profile

Phase I, Monocentric, Double-blind, Randomized Study to Assess Tolerability, Safety and Pharmacokinetics of ACH15 After Single Dose and Multiple Doses in Healthy Male Volunteers

Discontinued
Phase of Trial: Phase I

Latest Information Update: 21 Oct 2016

At a glance

  • Drugs ACH 15 (Primary)
  • Indications Inflammation
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Ache Laboratories
  • Most Recent Events

    • 18 Oct 2016 Planned End Date changed from 1 Apr 2014 to 1 Jun 2017.
    • 18 Oct 2016 Status changed from not yet recruiting to discontinued.
    • 10 Apr 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top